Cytiva™ HyClone™ Peak Expression Medium | B-LABO France
Cytiva™ HyClone™ Peak Expression Medium
Réf. : BL-RE-154503Réf. fabricant : 17878135
114,00 € HT
Ready-to-use medium supports growth and efficient transfection of adeno-associated virus (AAV) expression in HEK 293 cell lines.
Lignée cellulaire
HEK
Type de cellule
Embryonic Kidney
Classification
Viral Production
Culture Type
Mammalian Cell Culture
Système d’expression
Mammalian
Marque
Cytiva
This medium supports high cell growth, high transfection efficiency, and robust viral production for a variety of AAV serotypes expressed in human embryonic kidney (HEK) cell lines. HyClone™ peak expression medium is an animal-derived-component free (ADCF), hydrolysate-free and regulatory-friendly cell culture medium. The versatility of this medium allows high transfection efficiency, consistent cell growth, high viable cell density, and high viral titers across many HEK 293 cell lines and AAV serotypes.
HyClone™ peak expression medium supports a seamless transition from growth to production of AAV using standard cell lines and processes. HyClone™ peak expression medium is available in liquid and powder formats in user-friendly packaging.
Caractéristiques principales
Ready-to-use medium contains stable L-glutamine and poloxamer 188
Designed for high cell yield and robust virus production
Allows for direct adaptation
Designed for small- to large-scale transfection and production applications
Compatible with a variety of PEI- and lipid-based transfection reagents
Caractéristiques techniques
Marque
Cytiva
Réf. B-LABO
BL-RE-154503
Réf. fabricant
17878135
Lignée cellulaire
HEK
Type de cellule
Embryonic Kidney
Classification
Viral Production
Culture Type
Mammalian Cell Culture
Système d’expression
Mammalian
Forme
Liquid
Type de produit
Cell Culture Media
Stérilité
Sterile-filtered
Sterilization Method
0.2 μm Sterile-filtered
Avec additifs
Glutamine, Poloxamer 188
Sans additif
None
Volume reconstitué
1 L
Une question, une configuration particulière ? Contactez-nous pour un devis.